Opportunity Overview
LINE ITEM 0001- Lumens BE Digital Trio including SmartPulse
Edward Hines VA Medical Center has a requirement for Lumenis BE Digital Trio. This request is a sole source procurement for an SDVOSB company. T The clinical rooms at Hines are quite small and would benefit from the laser's compact dimensions. Retinal treatments are crucial as they address damage to the eye's light-sensitive tissue, helping to prevent vision loss or blindness caused by conditions such as diabetic retinopathy, macular degeneration, and retinal detachment. These procedures include laser photocoagulation to seal leaks, injections to reduce swelling, and surgeries to repair tears or remove scar tissue. The Lumenis system has a dual laser allows physicians to perform all anterior segment laser procedures while recording or taking pictures before, during, and after the procedure. These recordings can be used for training purposes.
Therefore, the Lumenis BE Digital Trio is the only platform that combines Selective Laser Trabeculoplasty, Yttrium Aluminum Garnet Laser, and a retinal care photocoagulator. It is designed as an all-inclusive digital and imaging solution, enhancing practice efficiency and providing advanced capabilities for laser therapy. The Digital Trio configuration incorporates a state-of-the-art retinal care photocoagulator into the digital dual-path SLT-YAG system.
Furthermore, the Digital Trio is a cutting-edge, multi-application laser platform that integrates SLT, YAG, and green photocoagulator capabilities into a single, compact system. Designed to enhance clinical efficiency, it utilizes one table and slit lamp for all treatments, ensuring a small footprint and true ADA compliance...
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | 252-Network Contract Office 12 (36C252) |
|---|---|
| Country | United States |
| Category | Pharmaceuticals |
| NAICS | 339112 |
| PSC | 6515 |
| Published | February 12, 2026 |
| Procurement stage | Active solicitation |
| Closed | February 12, 2026 |
| Status | Closed — no longer accepting responses |
| Translation | Translated from Estonian by GlobalGov’s translation pipeline |
| Official source | View original notice |
| Last verified | August 12, 2026 |
Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.
Browse Similar Open Opportunities in United States
See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United States Pharmaceuticals intelligence report in your inbox
A personalized report on United States Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.